ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
6.80
+0.30 (4.62%)
Oct 19, 2026, 11:56 AM EST
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $28.23 million as of October 19, 2026. It is the 34,820th most valuable company in the world and the 5,042nd biggest in the United States. Its market cap has decreased by 41.81% in one year.
Market Cap
28.23M
Enterprise Value
28.99M
Revenue
209.03K
Global Rank
Country Rank
#5,042 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 28.23M, an increase of 1,069.80%. That is a compound annual growth rate of 11.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 28.23M | -17.63% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 45.65M |
| Arch Biopartners | 38.76M |
| Biomind Labs | 35.68M |
| Cell Source | 33.63M |
| Aeternum Resources | 26.87M |
| Provectus Biopharmaceuticals | 20.47M |
| Inhibitor Therapeutics | 19.10M |
| HST Global | 18.91M |